Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess whether any relative benefit on overall survival (OS) from the combination of denosumab and standard of care (SOC) versus SOC alone in non-small cell lung cancer (NSCLC) is associated with tumor RANK expression
Critère d'inclusion
- non-small cell lung cancer